Product Code: ETC6188138 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias pharmaceutical market is well-established, supported by a strong regulatory framework, government funding under the Pharmaceutical Benefits Scheme (PBS), and a robust healthcare infrastructure. The sector includes both domestic production and importation, with innovation and R&D playing a pivotal role in market dynamics. Aging populations and increased chronic disease prevalence are driving demand.
The pharmaceutical market in Australia is showing steady growth driven by rising healthcare expenditure, an aging population, and increased prevalence of chronic diseases. Personalized medicine, advanced biologics, and telehealth integration are shaping the future of pharmaceuticals in the country. Regulatory reforms, including the Pharmaceutical Benefits Scheme (PBS), continue to influence drug pricing and accessibility, while international partnerships support drug innovation and market expansion.
The pharmaceutical market in Australia is influenced by several challenges, including increasing pressure to lower drug prices due to government regulations and healthcare system constraints. Additionally, the market is impacted by growing concerns about the accessibility of medicines, particularly for people in remote areas or those who cannot afford high-cost treatments. With the rapid pace of medical advancements, there is also a need for continuous investment in research and development to keep up with emerging diseases and treatment options.
The pharmaceutical market in Australia is shaped by strong investment policies that encourage innovation in drug development and manufacturing. The Australia government provides financial support for research and development through initiatives like the Medical Research Future Fund (MRFF), which offers grants for clinical trials and new treatment developments. Policies are designed to attract foreign investments, particularly in biotechnology and pharmaceutical sectors, with a focus on improving healthcare outcomes and expanding access to medicines. The Pharmaceutical Benefits Scheme (PBS) also plays a role in shaping the investment landscape by ensuring that medicines are affordable and accessible.
The Australia pharmaceutical market is regulated by the Therapeutic Goods Administration (TGA), which ensures that all pharmaceutical products meet strict safety, quality, and efficacy standards before reaching consumers. The government provides funding for medical research, including the development of new medications and therapies, to address unmet healthcare needs. Policies also ensure that pharmaceuticals are available to the public through the Pharmaceutical Benefits Scheme (PBS), which subsidizes the cost of medications for eligible individuals. Additionally, the government has initiatives to support the growth of the local pharmaceutical manufacturing sector, including policies aimed at improving the competitiveness and innovation of Australia pharmaceutical companies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2021 & 2031F |
3.6 Australia Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Australia Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Australia Pharmaceutical Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 Australia Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.10 Australia Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pharmaceutical Market Trends |
6 Australia Pharmaceutical Market, By Types |
6.1 Australia Pharmaceutical Market, By Prescription Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Market Revenues & Volume, By Prescription Type, 2021- 2031F |
6.1.3 Australia Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 Australia Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2021- 2031F |
6.2 Australia Pharmaceutical Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2021- 2031F |
6.2.3 Australia Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2021- 2031F |
6.2.4 Australia Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2021- 2031F |
6.3 Australia Pharmaceutical Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmaceutical Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.3.3 Australia Pharmaceutical Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3.4 Australia Pharmaceutical Market Revenues & Volume, By Biosimilars, 2021- 2031F |
6.4 Australia Pharmaceutical Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 Australia Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.4.3 Australia Pharmaceutical Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.4 Australia Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.4.5 Australia Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.4.6 Australia Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.7 Australia Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2021- 2031F |
6.5 Australia Pharmaceutical Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Australia Pharmaceutical Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.3 Australia Pharmaceutical Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 Australia Pharmaceutical Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5.5 Australia Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2021- 2031F |
6.5.6 Australia Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.6.3 Australia Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 Australia Pharmaceutical Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.5 Australia Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Australia Pharmaceutical Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Market Export to Major Countries |
7.2 Australia Pharmaceutical Market Imports from Major Countries |
8 Australia Pharmaceutical Market Key Performance Indicators |
9 Australia Pharmaceutical Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2021 & 2031F |
9.2 Australia Pharmaceutical Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Australia Pharmaceutical Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 Australia Pharmaceutical Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.5 Australia Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.6 Australia Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Pharmaceutical Market - Competitive Landscape |
10.1 Australia Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |